Results 161 to 170 of about 3,861,164 (348)

Persistent Leukoencephalopathy Following H1N1 Infection Associated With a Novel MYRF Variant (p.Gly735Asp)

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Mutations in myelin regulatory factor (MYRF) are linked to demyelinating disorders. We report a 38‐year‐old male who developed acute symmetric leukoencephalopathy mimicking a stroke following an influenza A virus infection. While clinical symptoms markedly improved with corticosteroids, MRI revealed persistent white matter lesions, contrasting
Jinghan Hu, Leiyun Huang, Wan Zhu, Min Peng, Qiang Gong, Jing Qian   +5 more
wiley   +1 more source

CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape

Nature, 2019
Mohamad Hamieh, Anton Dobrin, Annalisa Cabriolu, Sjoukje J. C. van der Stegen, Theodoros Giavridis, J. Mansilla-Soto, Justin Eyquem, Zeguo Zhao, Benjamin Whitlock, Matthew M. Miele, Zhuoning Li, K. Cunanan, M. Huse, R. Hendrickson, Xiuyan Wang, I. Rivière, M. Sadelain   +16 more
semanticscholar   +1 more source

Epidermal resident memory T cell fitness requires antigen encounter in the skin. [PDF]

Elife
Weiss ES, Hirai T, Li H, Liu A, Baker S, Magill I, Gillis J, Zhang YR, Ramcke T, Kurihara K, ImmGen Consortium OpenSource T cell Project, Masopust D, Anandasabapathy N, Singh H, Zemmour D, Mackay LK, Kaplan DH.   +16 more
europepmc   +1 more source

Optimal T cell activation by melanoma cells depends on a minimal level of antigen transcription. [PDF]

, 1997
Nathalie Labarrière, Elisabeth Viles, Marie‐Christine Pandolfino, Christophe Viret, Yannick Guilloux, Soizic Le Guiner, Jean‐François Fonteneau, Brigitte Dréno, Francine Jotereau   +8 more
openalex   +1 more source

Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐AChR Antibody‐Positive Myasthenia Gravis: FGF‐19 as a Novel Biomarker

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo, Deyou Peng, Zhouao Zhang, Mingjin Yang, Xinyan Guo, Tianyu Ma, Xiaoyu Huang, Mingming Xu, Linlin Fu, Yong Zhang   +9 more
wiley   +1 more source

Overcoming Resistance and Relapse in CAR-T and CAR-NK Cell Therapies: From Bench to Bedside. [PDF]

Research (Wash D C)
Wang Y, Shao W, Mao J, Ye Q.
europepmc   +1 more source

A 100-kDa Antigen Recognized by a Newly Prepared Monoclonal Antibody Specific to the Vanadocytes of the Vanadium-Rich Ascidian, Ascidia sydneiensis samea, is Glycogen Phosphorylase [PDF]

, 1998
Taro Uyama, Tatsuya Ueki, Yoshitake Suhama, Kan Kanamori, Hitoshi Michibata   +4 more
openalex   +1 more source

Histocompatibility antigens [PDF]

Eye, 1995
C J, Taylor, P A, Dyer
openaire   +2 more sources

Discovery and Targeted Proteomic Studies Reveal Striatal Markers Validated for Huntington's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Clinical trials for Huntington's disease (HD) enrolling persons before clinical motor diagnosis (CMD) lack validated biomarkers. This study aimed to conduct an unbiased discovery analysis and a targeted examination of proteomic biomarkers scrutinized by clinical validation. Methods Cerebrospinal fluid was obtained from PREDICT‐HD and
Daniel Chelsky, Cara Joyce, H. Jeremy Bockholt, Paul A. Rudnick, William H. Adams, Fiona McAllister, Justin W. Smock, Michael A. Newton, Jane S. Paulsen   +8 more
wiley   +1 more source

SARS-CoV-2 mRNA Vaccination Leads to Transient Humoral and B Cell Bystander Responses in Adults. [PDF]

Eur J Immunol
Kuijper LH, Kummer LYL, Blanco LF, van der Straten K, Claireaux MAF, Bos AV, Dieker-Meijer MC, Jorritsma T, Duurland MC, Steenhuis M, Vallejo JJG, van Dam KPJ, Stalman EW, Wieske L, Tas SW, Boekel L, Wolbink GJ, Rispens T, Kuijpers TW, Eftimov F, van Gils MJ, Ten Brinke A, van Ham SM, T2B! immunity against SARS‐CoV‐2 study group.   +23 more
europepmc   +1 more source